Prot# ION-682884-CS2: A Phase 3 Global, Double-Blind, Randomized, Placebo‑Controlled Study to Evaluate the Efficacy and Safety of ION-682884 in Patients with Transthyretin‑Mediated Amyloid Cardiomyopathy (ATTR CM)

Project: Research project

Project Details

StatusActive
Effective start/end date6/26/20 → 6/26/23

Funding

  • Pharmaceutical Research Associates, Inc. (Prot# ION-682884-CS2)
  • Ionis Pharmaceuticals, Inc. (Prot# ION-682884-CS2)